ArticleWorld journal of surgery2017

Peritherapeutic Serum p53 Antibody Titers are Predictors of Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy and Surgery.

Kotaro Yamashita et al.PubMed ↗Publisher ↗

No numbers read from the abstract.